Osterix promotes the migration and angiogenesis of breast cancer by upregulation of S100A4 expression

J Cell Mol Med. 2019 Feb;23(2):1116-1127. doi: 10.1111/jcmm.14012. Epub 2018 Nov 18.

Abstract

As a key transcription factor required for bone formation, osterix (OSX) has been reported to be overexpressed in various cancers, however, its roles in breast cancer progression remain poorly understood. In this study, we demonstrated that OSX was highly expressed in metastatic breast cancer cells. Moreover, it could upregulate the expression of S100 calcium binding protein A4 (S100A4) and potentiate breast cancer cell migration and tumor angiogenesis in vitro and in vivo. Importantly, inhibition of S100A4 impaired OSX-induced cell migration and capillary-like tube formation. Restored S100A4 expression rescued OSX-short hairpin RNA-suppressed cell migration and capillary-like tube formation. Moreover, the expression levels of OSX and S100A4 correlated significantly in human breast tumors. Our study suggested that OSX acts as an oncogenic driver in cell migration and tumor angiogenesis, and may serve as a potential therapeutic target for human breast cancer treatment.

Keywords: S100A4; angiogenesis; breast cancer; migration; osterix.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / genetics*
  • Breast Neoplasms / pathology
  • Cell Line
  • Cell Line, Tumor
  • Cell Movement / genetics*
  • Female
  • Gene Expression Regulation, Neoplastic / genetics
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • MCF-7 Cells
  • Neovascularization, Pathologic / genetics*
  • Neovascularization, Pathologic / pathology
  • RNA, Small Interfering / genetics
  • S100 Calcium-Binding Protein A4 / genetics*
  • Sp7 Transcription Factor / genetics*
  • Transcriptional Activation / genetics
  • Up-Regulation / genetics*

Substances

  • RNA, Small Interfering
  • S100 Calcium-Binding Protein A4
  • Sp7 Transcription Factor
  • SP7 protein, human
  • S100A4 protein, human